Integrating Obesity Management into Psoriasis Care: The Role of GLP-1 Therapies

Explore the biological pathways linking excess adiposity with systemic inflammation and treatment outcomes, with insights relevant to everyday clinical practice. Learners will review the epidemiology of obesity and its cardiometabolic implications, including factors that influence long-term patient health and treatment response. The program examines current evidence for GLP-1 receptor agonists and dual GIP/GLP-1 therapies, with a focus on efficacy, patient selection, and real-world clinical use.

Participants will gain practical guidance on incorporating weight-management interventions into dermatology care, such as identifying appropriate candidates for anti-obesity medications, setting weight-loss goals, and coordinating referrals to nutrition and obesity medicine specialists. Key considerations for safety, contraindications, adverse-effect management, and ongoing monitoring will be addressed through patient-centered scenarios and treatment decision-making examples. The activity also highlights multidisciplinary care strategies, including managing patients with cardiometabolic risk factors, optimizing treatment adherence, and integrating obesity management into comprehensive dermatologic care plans.